Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Stock Crosses Above Fifty Day Moving Average – What’s Next?

Bayer Aktiengesellschaft (OTCMKTS:BAYRYGet Free Report) crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $5.16 and traded as high as $5.47. Bayer Aktiengesellschaft shares last traded at $5.43, with a volume of 683,003 shares traded.

Bayer Aktiengesellschaft Stock Up 1.5 %

The company has a market capitalization of $21.34 billion, a PE ratio of -20.88 and a beta of 1.02. The firm’s 50-day simple moving average is $5.14 and its 200 day simple moving average is $6.64. The company has a debt-to-equity ratio of 1.19, a quick ratio of 0.81 and a current ratio of 1.32.

Bayer Aktiengesellschaft (OTCMKTS:BAYRYGet Free Report) last released its quarterly earnings results on Tuesday, November 12th. The company reported $0.07 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.17 by ($0.10). The firm had revenue of $10.96 billion for the quarter. Bayer Aktiengesellschaft had a positive return on equity of 16.90% and a negative net margin of 2.02%. As a group, equities research analysts forecast that Bayer Aktiengesellschaft will post 1.31 earnings per share for the current year.

Bayer Aktiengesellschaft Company Profile

(Get Free Report)

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.

Featured Stories

Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.